5-AZACITIDINE MAINTENANCE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK AML AND MDS

被引：0
|
作者：
Puglisi, Bruna
Saraceni, Francesco
Guerzoni, Selene
Scortechini, Ilaria
Mancini, Giorgia
Fiorentini, Alessandro
Lotito, Antonio
Colaneri, Francesca Romana
Federici, Irene
Olivieri, Attilio
机构：
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P307
引用
收藏
页码：364 / 365
页数：2
相关论文
共 50 条
  • [41] T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML
    Satty, Alexandra M.
    Klein, Elizabeth
    Mauguen, Audrey
    Kunvarjee, Binni
    Boelens, Jaap Jan
    Cancio, Maria
    Curran, Kevin J.
    Kernan, Nancy A.
    Prockop, Susan E.
    Scaradavou, Andromachi
    Spitzer, Barbara
    Tamari, Roni
    Ruggiero, Julianne
    Torok-Castanza, Joanne
    Mehta, Parinda A.
    O'Reilly, Richard J.
    Boulad, Farid
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 23 - 33
  • [42] T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML
    Alexandra M. Satty
    Elizabeth Klein
    Audrey Mauguen
    Binni Kunvarjee
    Jaap Jan Boelens
    Maria Cancio
    Kevin J. Curran
    Nancy A. Kernan
    Susan E. Prockop
    Andromachi Scaradavou
    Barbara Spitzer
    Roni Tamari
    Julianne Ruggiero
    Joanne Torok-Castanza
    Parinda A. Mehta
    Richard J. O’Reilly
    Farid Boulad
    Bone Marrow Transplantation, 2024, 59 : 23 - 33
  • [43] Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study
    De Lima, Marcos
    Silva, Leandro de Padua
    Giralt, Sergio
    Komanduri, Krishna
    Andersson, Borje S.
    Hosing, Chitra
    Qazilbash, Muzaffar
    Shpall, Elizabeth
    Thall, Peter
    Zhang, Weiqing
    McCormick, Gloria
    Wang, Xuemei
    Popat, Uday
    Soriano, Andres
    Alousi, Amin
    Champlin, Richard
    Garcia-Manero, Guillermo
    BLOOD, 2008, 112 (11) : 414 - 414
  • [44] A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1
    Guadagnuolo, Viviana
    Papayannidis, Cristina
    Lacobucci, Ilaria
    Simonetti, Giorgia
    Padella, Antonella
    Paolini, Stefania
    Abbenante, Mariachiara
    Parisi, Sarah
    Volpato, Francesca
    Sartor, Chiara
    Fontana, Maria Chiara
    Delledonne, Massimo
    Malagola, Michele
    Fili, Carla
    Russo, Domenico
    Grilli, Sandro
    Cavo, Michele
    Martinelli, Giovanni
    CANCER RESEARCH, 2015, 75
  • [45] A phase I b study of panobinostat and 5-azacitidine in Japanese patients with MDS, CMML, or AML
    Yakushijin, Kimikazu
    Minami, Hironobu
    Uchida, Toshiki
    Ogura, Michinori
    Taniwaki, Masafumi
    Kobayashi, Tsutomu
    Mori, Asuka
    Yonemura, Masataka
    Munakata, Wataru
    Kobayashi, Yukio
    ANNALS OF ONCOLOGY, 2015, 26 : 85 - 85
  • [46] Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Bewersdorf, Jan Philipp
    Derkach, Andriy
    Gowda, Lohith
    Menghrajani, Kamal
    DeWolf, Susan
    Ruiz, Josel D.
    Ponce, Doris M.
    Shaffer, Brian C.
    Tamari, Roni
    Young, James W.
    Jakubowski, Ann A.
    Gyurkocza, Boglarka
    Chan, Alexander
    Xiao, Wenbin
    Glass, Jacob
    King, Amber C.
    Cai, Sheng F.
    Daniyan, Anthony
    Famulare, Christopher
    Cuello, Bernadette M.
    Podoltsev, Nikolai A.
    Roshal, Mikhail
    Giralt, Sergio
    Perales, Miguel-Angel
    Seropian, Stuart
    Cho, Christina
    Zeidan, Amer M.
    Prebet, Thomas
    Stein, Eytan M.
    Tallman, Martin S.
    Goldberg, Aaron D.
    Stahl, Maximilian
    LEUKEMIA & LYMPHOMA, 2021, 62 (14) : 3394 - 3401
  • [47] Prior Azacitidine and Ongoing Transfusion Dependence in MDS Patients Are Associated with Inferior Survival after Allogeneic Stem Cell Transplant
    Horton, Miles
    Leung, Becky
    Nelles, Ricky
    Rubic, Matthew
    Mckinnely, Christopher
    Cibich, Alia
    Dowling, Mark R.
    Hunt, Stewart
    Chee, Lynette C. Y.
    Scott, Ashleigh P.
    Ritchie, David S.
    Hiwase, Devendra
    Purtill, Duncan
    Bhattacharya, Abir
    Kennedy, Glen A.
    Bajel, Ashish
    BLOOD, 2024, 144 : 7440 - 7441
  • [48] Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
    Amberge, Simon
    Kramer, Michael
    Schroettner, Percy
    Heidrich, Katharina
    Schmelz, Renate
    Middeke, Jan M.
    Gunzer, Florian
    Hampe, Jochen
    Schetelig, Johannes
    Bornhaeuser, Martin
    Stoelzel, Friedrich
    BONE MARROW TRANSPLANTATION, 2020, 55 (02) : 367 - 375
  • [49] Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome
    Simon Amberge
    Michael Kramer
    Percy Schröttner
    Katharina Heidrich
    Renate Schmelz
    Jan M. Middeke
    Florian Gunzer
    Jochen Hampe
    Johannes Schetelig
    Martin Bornhäuser
    Friedrich Stölzel
    Bone Marrow Transplantation, 2020, 55 : 367 - 375
  • [50] Impact of comorbidity on the outcome of allogeneic hematopoietic stem cell transplantation in AML/MDS patients.
    Shahjahan, M
    Alamo, J
    Delima, M
    Khouri, I
    Gajewski, J
    Andersson, BS
    Champlin, RE
    Giralt, S
    BLOOD, 2003, 102 (11) : 708A - 708A
12345